Overview
Status
Active
Registry date
2025-02-05
Share capital
5,000.00 PLN
Registered address
ul. Barska 7, 02-316 Warszawa, Poland
Industry
Authorized Representatives
Loubana Naser Aldeen – Management Board Member
Mahmoud Mohammed Mohammed – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mahmoud Mohammed Mohammedage 42 | 50 | $675.31 | 50% |
Loubana Naser Aldeenage 35 | 50 | $675.31 | 50% |
Beneficial owners
No beneficial owners recorded for the company LEK Med.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
The main business activity of LEK Med focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on February 5, 2025.
The headquarters is located at: ul. Barska 7, 02-316 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-17